These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 27254086)
1. Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study. Jha SC; Meltzer-Brody S; Steiner RJ; Cornea E; Woolson S; Ahn M; Verde AR; Hamer RM; Zhu H; Styner M; Gilmore JH; Knickmeyer RC Psychiatry Res Neuroimaging; 2016 Jul; 253():43-53. PubMed ID: 27254086 [TBL] [Abstract][Full Text] [Related]
2. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy. Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692 [TBL] [Abstract][Full Text] [Related]
3. Antenatal exposure to antidepressants is associated with altered brain development in very preterm-born neonates. Podrebarac SK; Duerden EG; Chau V; Grunau RE; Synnes A; Oberlander TF; Miller SP Neuroscience; 2017 Feb; 342():252-262. PubMed ID: 27890829 [TBL] [Abstract][Full Text] [Related]
4. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory. Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036 [TBL] [Abstract][Full Text] [Related]
5. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure. Knickmeyer RC; Meltzer-Brody S; Woolson S; Hamer RM; Smith JK; Lury K; Gilmore JH Neuropsychopharmacology; 2014 Oct; 39(11):2611-21. PubMed ID: 24837031 [TBL] [Abstract][Full Text] [Related]
6. Intrauterine Exposure to Antidepressants or Maternal Depressive Symptoms and Offspring Brain White Matter Trajectories From Late Childhood to Adolescence. Koc D; El Marroun H; Stricker BH; Muetzel RL; Tiemeier H Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Feb; 9(2):217-226. PubMed ID: 37926188 [TBL] [Abstract][Full Text] [Related]
7. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066 [TBL] [Abstract][Full Text] [Related]
8. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants. Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992 [TBL] [Abstract][Full Text] [Related]
9. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain. Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808 [TBL] [Abstract][Full Text] [Related]
10. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923 [TBL] [Abstract][Full Text] [Related]
15. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704 [TBL] [Abstract][Full Text] [Related]
16. Advanced neuroimaging: A window into the neural correlates of fetal programming related to prenatal exposure to maternal depression and SSRIs. Rotem-Kohavi N; Williams LJ; Oberlander TF Semin Perinatol; 2020 Apr; 44(3):151223. PubMed ID: 32122645 [TBL] [Abstract][Full Text] [Related]
17. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month. Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656 [TBL] [Abstract][Full Text] [Related]
18. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202 [TBL] [Abstract][Full Text] [Related]
19. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Engelstad HJ; Roghair RD; Calarge CA; Colaizy TT; Stuart S; Haskell SE Neonatology; 2014; 105(2):149-54. PubMed ID: 24356332 [TBL] [Abstract][Full Text] [Related]
20. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure. Rotem-Kohavi N; Oberlander TF Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]